Dow Up 0.07% Nasdaq Up 0.61%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.84 Up 0.06(1.04%) Nov 26, 4:00PM EST
Prev Close:5.78
Open:5.80
Bid:N/A
Ask:6.45 x 100
1y Target Est:11.33
Beta:3.84
Next Earnings Date:N/A
Day's Range:5.62 - 5.85
52wk Range:3.11 - 7.82
Volume:2,387,248
Avg Vol (3m):4,530,580
Market Cap:719.29M
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXUp 1.04%719.29M
ABTUp 0.20%66.63B
GSKUp 0.52%111.83B
RHHBYUp 0.54%254.20B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Dec-14) :0.23
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-3.82

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback